These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1085 related items for PubMed ID: 12392341

  • 21. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG.
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [Abstract] [Full Text] [Related]

  • 22. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH, Miller F, Walt SE, Waugh MC, Stott NS.
    Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [Abstract] [Full Text] [Related]

  • 24. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
    Albani G, Cimolin V, Galli M, Vimercati S, Bar D, Campanelli L, Gandolfi R, Lombardi R, Mauro A.
    Funct Neurol; 2010 May; 25(2):103-7. PubMed ID: 20923608
    [Abstract] [Full Text] [Related]

  • 25. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC.
    Arch Phys Med Rehabil; 2018 Nov; 99(11):2143-2150. PubMed ID: 30392753
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y, Wu T, Hu X, Wang T.
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [Abstract] [Full Text] [Related]

  • 27. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
    Gracies JM, O'Dell M, Vecchio M, Hedera P, Kocer S, Rudzinska-Bar M, Rubin B, Timerbaeva SL, Lusakowska A, Boyer FC, Grandoulier AS, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
    [Abstract] [Full Text] [Related]

  • 28. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
    Santamato A, Panza F, Filoni S, Ranieri M, Solfrizzi V, Frisardi V, Dellomonaco A, Amoruso MT, Amoruso L, Kehoe PG, Megna M, Fiore P.
    Brain Inj; 2010 Feb; 24(9):1108-12. PubMed ID: 20569045
    [Abstract] [Full Text] [Related]

  • 29. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 30. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):395-400. PubMed ID: 12167681
    [Abstract] [Full Text] [Related]

  • 31. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N, Logroscino G, Fiore P, Ranieri M.
    Clin Rehabil; 2015 Jan 08; 29(1):50-8. PubMed ID: 24917588
    [Abstract] [Full Text] [Related]

  • 32. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A, Panza F, Intiso D, Baricich A, Picelli A, Smania N, Fortunato F, Seripa D, Fiore P, Ranieri M.
    J Neurol Sci; 2017 Jul 15; 378():182-186. PubMed ID: 28566161
    [Abstract] [Full Text] [Related]

  • 33. [Mapping of motor-points in the flexor muscles of the arm for the optimization of botulinum toxin injections in treatment of spasticity].
    Kovalenko AP, Misikov VK, Sinelnikov KA, Karimov AN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017 Jul 15; 117(7):47-52. PubMed ID: 28805760
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct 15; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 35. Quantifying patterns of upper limb motor change following BTX-A injection in adult spasticity management.
    Barden HL, Baguley IJ, Nott MT, Chapparo C.
    Brain Inj; 2015 Oct 15; 29(12):1452-9. PubMed ID: 26305105
    [Abstract] [Full Text] [Related]

  • 36. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A, Vallies G, Chemello E, Gavras A, Castellazzi P, Meschieri A, Serina A, Gandolfi M, Baricich A, Santamato A, Cisari C, Smania N.
    J Rehabil Med; 2017 May 16; 49(5):410-415. PubMed ID: 28471469
    [Abstract] [Full Text] [Related]

  • 37. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.
    J Rehabil Med; 2011 Nov 16; 43(11):1032-7. PubMed ID: 22031350
    [Abstract] [Full Text] [Related]

  • 38. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
    Picelli A, Lobba D, Midiri A, Prandi P, Melotti C, Baldessarelli S, Smania N.
    Clin Rehabil; 2014 Mar 16; 28(3):232-42. PubMed ID: 23945164
    [Abstract] [Full Text] [Related]

  • 39. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.
    J Rehabil Med; 2009 Jun 16; 41(7):536-44. PubMed ID: 19543664
    [Abstract] [Full Text] [Related]

  • 40. Quantitative assessment for flexed-elbow deformity during gait following botulinum toxin A treatment.
    Tanikawa H, Kagaya H, Inagaki K, Kotsuji Y, Suzuki K, Fujimura K, Mukaino M, Hirano S, Saitoh E, Kanada Y.
    Gait Posture; 2018 May 16; 62():409-414. PubMed ID: 29649706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.